SIBN
SI-BONE Inc (SIBN)
Healthcare • NASDAQ • $12.27-5.25%
- Symbol
- SIBN
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $12.27
- Daily Change
- -5.25%
- Market Cap
- $542.87M
- Trailing P/E
- N/A
- Forward P/E
- -32.17
- 52W High
- $21.89
- 52W Low
- $11.80
- Analyst Target
- $25.50
- Dividend Yield
- N/A
- Beta
- 0.67
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-m…
Company websiteResearch SIBN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.